B. Metzler seel. Sohn & Co. Holding AG Takes Position in Innospec Inc. (NASDAQ:IOSP)

B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of Innospec Inc. (NASDAQ:IOSP - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 32,947 shares of the specialty chemicals company's stock, valued at approximately $3,726,000. B. Metzler seel. Sohn & Co. Holding AG owned 0.13% of Innospec as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. DekaBank Deutsche Girozentrale bought a new stake in shares of Innospec in the 1st quarter worth approximately $66,000. CWM LLC grew its stake in Innospec by 239.6% in the 2nd quarter. CWM LLC now owns 635 shares of the specialty chemicals company's stock valued at $78,000 after buying an additional 448 shares in the last quarter. Blue Trust Inc. lifted its holdings in Innospec by 503.9% during the 3rd quarter. Blue Trust Inc. now owns 779 shares of the specialty chemicals company's stock worth $96,000 after purchasing an additional 650 shares in the last quarter. nVerses Capital LLC boosted its position in shares of Innospec by 200.0% in the third quarter. nVerses Capital LLC now owns 900 shares of the specialty chemicals company's stock valued at $102,000 after acquiring an additional 600 shares during the period. Finally, EntryPoint Capital LLC purchased a new position in shares of Innospec during the 1st quarter valued at $147,000. Institutional investors own 96.64% of the company's stock.

Insider Buying and Selling

In other news, CFO Ian Cleminson sold 3,398 shares of the firm's stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $114.74, for a total value of $389,886.52. Following the completion of the sale, the chief financial officer now directly owns 12,996 shares of the company's stock, valued at approximately $1,491,161.04. This trade represents a 20.73 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Milton C. Blackmore sold 1,035 shares of Innospec stock in a transaction dated Wednesday, November 13th. The shares were sold at an average price of $122.92, for a total transaction of $127,222.20. Following the sale, the director now directly owns 9,028 shares in the company, valued at $1,109,721.76. The trade was a 10.29 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 11,035 shares of company stock valued at $1,267,096 over the last quarter. 1.52% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut shares of Innospec from a "strong-buy" rating to a "buy" rating in a research report on Thursday, August 8th.

Innospec Trading Up 1.3 %

IOSP opened at $118.25 on Thursday. The stock has a market capitalization of $2.95 billion, a P/E ratio of 20.64 and a beta of 1.08. The stock has a 50-day moving average price of $113.41 and a 200-day moving average price of $118.75. Innospec Inc. has a 12-month low of $103.97 and a 12-month high of $133.71.

Innospec (NASDAQ:IOSP - Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $1.35. Innospec had a net margin of 7.68% and a return on equity of 13.33%. The business had revenue of $443.40 million for the quarter, compared to analyst estimates of $442.13 million. During the same quarter last year, the firm earned $1.59 EPS. The company's revenue was down 4.5% on a year-over-year basis. On average, equities research analysts predict that Innospec Inc. will post 5.88 EPS for the current year.

Innospec Increases Dividend

The firm also recently declared a Semi-Annual dividend, which will be paid on Tuesday, November 26th. Investors of record on Monday, November 18th will be paid a $0.79 dividend. This is a positive change from Innospec's previous Semi-Annual dividend of $0.72. The ex-dividend date of this dividend is Monday, November 18th. This represents a yield of 1.3%. Innospec's dividend payout ratio (DPR) is presently 27.57%.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.